Doreen Schwarck-Kokarakis

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Uğur Şahin, Petra Oehm, Evelyna Derhovanessian et al. · Nature · 2020 · 1K citations

Medicine, Immunology, Oncology +14

A shared tumor-antigen RNA-lipoplex vaccine with/without anti-PD1 in patients with checkpoint-inhibition experienced melanoma.

Carmen Loquai, Jessica C. Hassel, Petra Oehm et al. · Journal of Clinical Oncology · 2020 · 21 citations

Medicine, Immunology, Oncology +17

Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma

Robert A. Jabulowsky, Carmen Loquai, Heidrun Mitzel-Rink et al. · Cancer Research · 2018 · 12 citations

Veterinary Medicine, Immunology, Oncology +17

A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy

Ludwig Heesen, Robert A. Jabulowsky, Carmen Loquai et al. · Annals of Oncology · 2017 · 10 citations

Life Sciences, Molecular Pharmaceutics, Oncology +17

549 An RNA-lipoplex (RNA-LPX) vaccine demonstrates strong immunogenicity and promising clinical activity in a Phase I trial in cutaneous melanoma patients with no evidence of disease at trial inclusion

Carmen Loquai, Jessica C. Hassel, Patrick T. Bruck et al. · Regular and Young Investigator Award Abstracts · 2021 · 10 citations · Full text

Medicine, Immunology, Oncology +17